Tags

Type your tag names separated by a space and hit enter

Update on rimonabant--a selective cannabinoid CB1 antagonist.
Ann Pharmacother. 2006 May; 40(5):994.AP

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Letter

Language

eng

PubMed ID

16638915

Citation

Boyd, Steven T., and Brad Allen Fremming. "Update On Rimonabant--a Selective Cannabinoid CB1 Antagonist." The Annals of Pharmacotherapy, vol. 40, no. 5, 2006, p. 994.
Boyd ST, Fremming BA. Update on rimonabant--a selective cannabinoid CB1 antagonist. Ann Pharmacother. 2006;40(5):994.
Boyd, S. T., & Fremming, B. A. (2006). Update on rimonabant--a selective cannabinoid CB1 antagonist. The Annals of Pharmacotherapy, 40(5), 994.
Boyd ST, Fremming BA. Update On Rimonabant--a Selective Cannabinoid CB1 Antagonist. Ann Pharmacother. 2006;40(5):994. PubMed PMID: 16638915.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Update on rimonabant--a selective cannabinoid CB1 antagonist. AU - Boyd,Steven T, AU - Fremming,Brad Allen, Y1 - 2006/04/25/ PY - 2006/4/28/pubmed PY - 2006/8/1/medline PY - 2006/4/28/entrez SP - 994 EP - 994 JF - The Annals of pharmacotherapy JO - Ann Pharmacother VL - 40 IS - 5 SN - 1060-0280 UR - https://www.unboundmedicine.com/medline/citation/16638915/Update_on_rimonabant__a_selective_cannabinoid_CB1_antagonist_ L2 - https://journals.sagepub.com/doi/10.1345/aph.1G713?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -